Boston University Libraries OpenBU
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    •   OpenBU
    • Centers & Institutes
    • Flow Cytometry Core Facility
    • Flow Cytometry Core Facility Papers
    • View Item
    •   OpenBU
    • Centers & Institutes
    • Flow Cytometry Core Facility
    • Flow Cytometry Core Facility Papers
    • View Item

    Targeting tumor multicellular aggregation through IGPR-1 inhibits colon cancer growth and improves chemotherapy

    Thumbnail
    License
    Attribution 3.0 United States
    Date Issued
    2017-09-18
    Publisher Version
    10.1038/oncsis.2017.77
    Author(s)
    Woolf, N.
    Pearson, B.E.
    Bondzie, P.A.
    Meyer, R.D.
    Lavaei, M.
    Belkina, A.C.
    Rahimi, N.
    Share to FacebookShare to TwitterShare by Email
    Export Citation
    Download to BibTex
    Download to EndNote/RefMan (RIS)
    Metadata
    Show full item record
    Permanent Link
    https://hdl.handle.net/2144/26191
    Citation (published version)
    N Woolf, BE Pearson, PA Bondzie, RD Meyer, M Lavaei, AC Belkina, V Chitalia and N Rahimi. Targeting tumor multicellular aggregation through IGPR-1 inhibits colon cancer growth and improves chemotherapy. Oncogenesis. 2017 Sep 18;6(9):e378. doi: 10.1038/oncsis.2017.77
    Abstract
    Adhesion to extracellular matrix (ECM) is crucially important for survival of normal epithelial cells as detachment from ECM triggers specific apoptosis known as anoikis. As tumor cells lose the requirement for anchorage to ECM, they rely on cell-cell adhesion 'multicellular aggregation' for survival. Multicellular aggregation of tumor cells also significantly determines the sensitivity of tumor cells to the cytotoxic effects of chemotherapeutics. In this report, we demonstrate that expression of immunoglobulin containing and proline-rich receptor-1 (IGPR-1) is upregulated in human primary colon cancer. Our study demonstrates that IGPR-1 promotes tumor multicellular aggregation, and interfering with its adhesive function inhibits multicellular aggregation and, increases cell death. IGPR-1 supports colon carcinoma tumor xenograft growth in mouse, and inhibiting its activity by shRNA or blocking antibody inhibits tumor growth. More importantly, IGPR-1 regulates sensitivity of tumor cells to the chemotherapeutic agent, doxorubicin/adriamycin by a mechanism that involves doxorubicin-induced AKT activation and phosphorylation of IGPR-1 at Ser220. Our findings offer novel insight into IGPR-1's role in colorectal tumor growth, tumor chemosensitivity, and as a possible novel anti-cancer target.
    Rights
    Attribution 3.0 United States
    Collections
    • Flow Cytometry Core Facility Papers [13]


    Boston University
    Contact Us | Send Feedback | Help
     

     

    Browse

    All of OpenBUCommunities & CollectionsIssue DateAuthorsTitlesSubjectsThis CollectionIssue DateAuthorsTitlesSubjects

    Deposit Materials

    LoginNon-BU Registration

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Boston University
    Contact Us | Send Feedback | Help